Expression of vascular endothelial growth factor protein in human renal cell carcinoma

BJU International

Volumn 93, Issue 3, 2004, Pages 297-302

  Jacobsen, J ^a   Grankvist, K ^a   Rasmuson, T ^a   Bergh, A ^a   Landberg, G ^b   Ljungberg, B ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Prognosis; Renal cell cancer; Stage; Survival; VEGF

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CANCER TISSUE; CELL MEMBRANE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DENSITY; EVALUATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SCALE UP; STAINING; STATISTICAL SIGNIFICANCE; STORAGE; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 1342288873     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2004.04605.x     Document Type: Article

References (26)

1. Ferrara N. Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int 1999; 56: 794-814
2. Blancher C, Moore JW, Robertson N, Harris AL. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3′-kinase/Akt signaling pathway. Cancer Res 2001; 61: 7349-55
3. Bochner BH, Cote RJ, Weidner N et al. Angiogenesis in bladder cancer, relationship between microvessel density and tumor prognosis. J Natl Cancer Inst 1995; 87: 1603-12
4. MacLennan GT, Bostwick DG. Microvessel density in renal cell carcinoma, lack of prognostic significance. Urology 1995; 46: 27-30
5. Nativ O, Sabo E, Reiss A, Wald M, Madjar S, Moskovitz B. Clinical significance of tumor angiogenesis in patients with localized renal cell carcinoma. Urology 1998; 51: 693-6
6. Paradis V, Lagha NB, Zeimoura L et al. Expression of vascular endothelial growth factor in renal cell carcinomas. Virchows Arch 2000; 436: 351-6
7. Zhang X, Yamashita M, Uetsuki H, Kakehi Y. Angiogenesis in renal cell carcinoma. Evaluation of microvessel density, vascular endothelial growth factor and matrix metalloproteinases. Int J Urol 2002; 9: 509-14
8. Kononen J, Bubendorf L, Kallioniemi A et al. P. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nature Med 1998; 4: 844-7
9. Camp RL, Charette LA, Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Inves 2000; 80: 1943-9
10. Sobin LH, Fleming ID.TNM Classification of Malignant Tumors 1997. 5th edn. Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997; 80: 1803-4
11. Skinner DG, Colvin RB, Vermillion CD, Pfister RC, Leadbetter WF. Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases. Cancer 1971; 28: 1165-77
12. Kovacs G, Akhtar M, Beckwith BJ et al. The Heidelberg classification of renal cell tumours. J Pathol 1997; 183: 131-3
13. Kovacs G. Papillary renal cell carcinoma. A morphologic and cytogenetic study of 11 cases. Am J Pathol 1989; 134: 27-34
14. Jacobsen J, Rasmuson T, Grankvist K, Ljunberg B. Vascular endothelial growth factor as prognostic factor in renal cell carcinoma. J Urol 2000; 163: 343-7
15. Nicol D, Hii SI, Walsh M et al. Vascular endothelial growth factor expression is increased in renal cell carcinoma. J Urol 1997; 157: 1482-6
16. Ortega N, Hutchings H, Plouet J. Signal relays in the VEGF system. Front Biosci 1999; 4: D141-52
17. Nakagawa M, Emoto A, Hanada T, Nasu N, Nomura Y. Tubulogenesis by microvascular endothelial cells is mediated by vascular endothelial growth factor (VEGF) in renal cell carcinoma. Br J Urol 1997; 79: 681-7
18. Brown LF, Berse B, Tognazzi K et al. Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int 1992; 42: 1457-61
19. Dvorak HF, Sioussat TM, Brown LF et al. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J Exp Med 1991; 174: 1275-8
20. Yoshino S, Kato M, Okada K. Evaluation of the prognostic significance of microvessel count and tumor size in renal cell carcinoma. Int J Urol 1998; 5: 119-23
21. Fang J, Yan L, Shing Y, Moses MA. HIF-1alpha-mediated up-regulation of vascular endothelial growth factor, independent of basic fibroblast growth factor, is important in the switch to the angiogenic phenotype during early tumorigenesis. Cancer Res 2001; 61: 5731-5
22. Maxwell PH, Wiesener MS, Chang GW et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999; 399: 271-5
23. Blath RA, Mancilla-Jimenez R, Stanley R. J. Clinical comparison between vascular and avascular renal cell carcinoma. J Urol 1976; 115: 514-9
24. Amin BM, Corless CL, Renshaw AA, Tickoo SS, Kubus J, Schultz DS. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases. Am J Surg Pathol 1997; 21: 621-35
25. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989; 49: 6449-65
26. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 843-5